Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Toolgen is a biotechnology company built on gene-editing technology. The company develops foundational CRISPR/Cas9 gene-editing technology, which it leverages to create a range of therapeutics, such as gene therapies and immuno-oncology drugs, and to supply research reagents. Its primary business focus lies in advancing gene-editing technology and developing novel drugs based on these applications.
툴젠은 유전자가위 기술을 기반으로 하는 생명공학 기업입니다. 크리스퍼(CRISPR/Cas9) 유전자가위 원천기술을 개발하고 이를 활용하여 유전자치료제, 면역항암제 등 다양한 치료제 개발 및 연구용 시약을 제공합니다. 주요 사업 영역은 유전자교정 기술 개발 및 이를 적용한 신약 개발입니다.
